Literature DB >> 2653853

Modulation of transferrin receptor expression and function by anti-transferrin receptor antibodies and antibody fragments.

J Lesley1, R Schulte, J Woods.   

Abstract

It has been suggested that effects of anti-transferrin receptor antibodies on cell growth and receptor expression are the result of varying degrees of receptor crosslinking by bi- and multivalet binding agents. In order to study this question directly, we have cultured murine lymphoma cells in mono- and divalent fragments from IgG and IgM monoclonal anti-transferrin receptor antibodies and in intact antibodies. The studies presented here demonstrate that effects of antibody binding on transferrin receptor distribution, metabolism, and function depend, at least in part, on antibody valence, and therefore on the degree of crosslinking of receptors by antibody. We found that monovalent antibody fragments did not significantly alter cell growth, receptor surface expression, intracellular localization, or degradation. Diavalent antibody caused a uniform down-regulation of cell-surface receptor expression, which was accompanied by increased degradation only when antibody Fc was present. Normal receptor cycling apparently continued, despite the reduction in surface expression. Culture in multivalent IgM antibody, however, resulted in accumulation of antibody-complexed receptor on the cell surface without internalization and caused profound inhibition of cell growth. Thus, we show two mechanisms by which different degrees of antibody crosslinking can influence transferrin receptor function: by receptor down-regulation and blocking internalization.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2653853     DOI: 10.1016/0014-4827(89)90293-0

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  18 in total

1.  Roles of rapsyn and agrin in interaction of postsynaptic proteins with acetylcholine receptors.

Authors:  C Fuhrer; M Gautam; J E Sugiyama; Z W Hall
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

2.  An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells.

Authors:  Patrick P Ng; Jay S Dela Cruz; David N Sorour; James M Stinebaugh; Seung-Uon Shin; Daniel S Shin; Sherie L Morrison; Manuel L Penichet
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

3.  Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier.

Authors:  P M Friden; L R Walus; G F Musso; M A Taylor; B Malfroy; R M Starzyk
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

4.  Persistence of zinc-binding bacterial superantigens at the surface of antigen-presenting cells contributes to the extreme potency of these superantigens as T-cell activators.

Authors:  Dorothy D Pless; Gordon Ruthel; Emily K Reinke; Robert G Ulrich; Sina Bavari
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

5.  Antibodies to cell surface proteins redirect intracellular trafficking pathways.

Authors:  Christine A St Pierre; Deborah Leonard; Silvia Corvera; Evelyn A Kurt-Jones; Robert W Finberg
Journal:  Exp Mol Pathol       Date:  2011-07-23       Impact factor: 3.362

6.  Toxic and Physiological Metal Uptake and Release by Human Serum Transferrin.

Authors:  David J Reilley; Jack T Fuller; Michael R Nechay; Marie Victor; Wei Li; Josiah D Ruberry; Jon I Mujika; Xabier Lopez; Anastassia N Alexandrova
Journal:  Biophys J       Date:  2020-05-20       Impact factor: 4.033

7.  Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor.

Authors:  Patrick P Ng; Gustavo Helguera; Tracy R Daniels; Simon Z Lomas; Jose A Rodriguez; Gary Schiller; Benjamin Bonavida; Sherie L Morrison; Manuel L Penichet
Journal:  Blood       Date:  2006-06-27       Impact factor: 22.113

8.  Association of muscle-specific kinase MuSK with the acetylcholine receptor in mammalian muscle.

Authors:  C Fuhrer; J E Sugiyama; R G Taylor; Z W Hall
Journal:  EMBO J       Date:  1997-08-15       Impact factor: 11.598

9.  Cellular determinants for preclinical activity of a novel CD33/CD3 bispecific T-cell engager (BiTE) antibody, AMG 330, against human AML.

Authors:  George S Laszlo; Chelsea J Gudgeon; Kimberly H Harrington; Justine Dell'Aringa; Kathryn J Newhall; Gary D Means; Angus M Sinclair; Roman Kischel; Stanley R Frankel; Roland B Walter
Journal:  Blood       Date:  2013-12-05       Impact factor: 22.113

10.  Syntaxin 7 and VAMP-7 are soluble N-ethylmaleimide-sensitive factor attachment protein receptors required for late endosome-lysosome and homotypic lysosome fusion in alveolar macrophages.

Authors:  D M Ward; J Pevsner; M A Scullion; M Vaughn; J Kaplan
Journal:  Mol Biol Cell       Date:  2000-07       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.